10-Q Filing

GUARDANT HEALTH, INC. CIK: 1576280 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001576280-23-000187`
Period End Date	20230930
Filing Date	20231106
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	gh-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 84 Cash Flow Statement 94 Stockholders Equity 44 Comprehensive Income 20

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value (in usd per share)	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$158.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.65M	USD	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$457.34M	USD	Point-in-time
Preferred stock issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Short-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$869.58M	USD	Point-in-time
Short-term marketable debt securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$697.48M	USD	Point-in-time
Preferred stock outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$88.80M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$97.26M	USD	Point-in-time
Common stock, par value (in usd per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventory, net	`InventoryNet`	$77.04M	USD	Point-in-time
Inventory, net	`InventoryNet`	$51.60M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$26.24M	USD	Point-in-time
Prepaid expenses and other current assets, net	`PrepaidExpenseAndOtherAssetsCurrent`	$31.51M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	102.62M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	117.85M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	117.85M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	102.62M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.19B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.35B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$167.92M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$147.67M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$161.67M	USD	Point-in-time
Right-of-use assets, net	`OperatingLeaseRightOfUseAsset`	$174.00M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$11.73M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$9.67M	USD	Point-in-time
Goodwill	`Goodwill`	$3.29M	USD	Point-in-time
Goodwill	`Goodwill`	$3.29M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$128.03M	USD	Point-in-time
Other assets, net	`OtherAssetsNoncurrent`	$61.45M	USD	Point-in-time
Total Assets	`Assets`	$1.61B	USD	Point-in-time
Total Assets	`Assets`	$1.80B	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$205.27M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$175.82M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$21.48M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$17.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$226.75M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$193.22M	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$1.14B	USD	Point-in-time
Convertible senior notes, net	`ConvertibleDebtNoncurrent`	$1.14B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$192.68M	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$210.01M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$10.18M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$9.18M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.55B	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.57B	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022	`PreferredStockValueOutstanding`	-	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of September 30, 2023, and December 31, 2022; 117,849,155 and 102,619,383 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Common stock, par value of $0.00001 per share; 350,000,000 shares authorized as of September 30, 2023, and December 31, 2022; 117,849,155 and 102,619,383 shares issued and outstanding as of September 30, 2023, and December 31, 2022, respectively	`CommonStockValueOutstanding`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.74B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.19B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-19.52M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.68M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.66B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.95B	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$228.30M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$166.75M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$60.18M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$292.73M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$645.00M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$319.09M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.61B	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$1.80B	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$278.25M	USD	3 Qtrs
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$102.05M	USD	1 Quarter
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$372.06M	USD	3 Qtrs
Precision oncology testing	`RevenueFromPrecisionOncologyTesting`	$133.42M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$44.40M	USD	3 Qtrs
Development services and other	`RevenueFromDevelopmentServices`	$15.35M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$9.61M	USD	1 Quarter
Development services and other	`RevenueFromDevelopmentServices`	$36.83M	USD	3 Qtrs
Total revenue	`Revenues`	$322.65M	USD	3 Qtrs
Total revenue	`Revenues`	$117.40M	USD	1 Quarter
Total revenue	`Revenues`	$408.89M	USD	3 Qtrs
Total revenue	`Revenues`	$143.03M	USD	1 Quarter
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$104.49M	USD	3 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$148.11M	USD	3 Qtrs
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$39.43M	USD	1 Quarter
Cost of precision oncology testing	`CostsOfPrecisionOncologyTesting`	$53.65M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$4.71M	USD	3 Qtrs
Cost of development services and other	`CostOfDevelopmentServices`	$1.06M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$3.97M	USD	1 Quarter
Cost of development services and other	`CostOfDevelopmentServices`	$16.42M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$267.23M	USD	3 Qtrs
Research and development expense	`ResearchAndDevelopmentExpense`	$93.85M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$100.02M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$277.34M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$216.10M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$218.41M	USD	3 Qtrs
Sales and marketing expense	`SellingAndMarketingExpense`	$68.93M	USD	1 Quarter
Sales and marketing expense	`SellingAndMarketingExpense`	$80.37M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$36.17M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$126.07M	USD	3 Qtrs
General and administrative expense	`GeneralAndAdministrativeExpense`	$41.12M	USD	1 Quarter
General and administrative expense	`GeneralAndAdministrativeExpense`	$118.14M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$776.11M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$720.91M	USD	3 Qtrs
Total costs and operating expenses	`CostsAndExpenses`	$256.57M	USD	1 Quarter
Total costs and operating expenses	`CostsAndExpenses`	$262.00M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-367.21M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-113.54M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-398.26M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-144.60M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$3.92M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.75M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$11.69M	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$21.48M	USD	3 Qtrs
Interest expense	`InterestExpense`	$644.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.93M	USD	3 Qtrs
Interest expense	`InterestExpense`	$644.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.93M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$56.49M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-18.06M	USD	3 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$16.89M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-18.39M	USD	1 Quarter
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	$-99.78M	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	1 Quarter
Fair value adjustments of noncontrolling interest liability	`FairValueOptionChangesInFairValueGainLoss1`	-	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-85.61M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-161.88M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-291.18M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-514.12M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$490.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$115.00K	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$537.00K	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$1.23M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-292.41M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-514.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-161.99M	USD	1 Quarter
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-5.04	USD	3 Qtrs
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-2.66	USD	3 Qtrs
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-1.58	USD	1 Quarter
Net loss per share, basic (in usd per share)	`EarningsPerShareBasic`	$-0.73	USD	1 Quarter
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-1.58	USD	1 Quarter
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-2.66	USD	3 Qtrs
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-0.73	USD	1 Quarter
Net loss per share, diluted (in usd per share)	`EarningsPerShareDiluted`	$-5.04	USD	3 Qtrs
Weighted-average shares used in computing net loss per share, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	109.79M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	117.74M	shares	1 Quarter
Weighted-average shares used in computing net loss per share, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.06M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.29M	shares	1 Quarter
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.06M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.29M	shares	1 Quarter
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	109.79M	shares	3 Qtrs
Weighted-average shares used in computing net loss per share, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	117.74M	shares	1 Quarter

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-292.41M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-514.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-161.99M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.79M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$32.01M	USD	3 Qtrs
Operating lease costs	`NonCashOperatingLeaseCosts`	$21.39M	USD	3 Qtrs
Operating lease costs	`NonCashOperatingLeaseCosts`	$22.15M	USD	3 Qtrs
Contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$4.20M	USD	3 Qtrs
Contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$230.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$70.98M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$66.44M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.93M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.93M	USD	3 Qtrs
Amortization of (discount) premium on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.37M	USD	3 Qtrs
Amortization of (discount) premium on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$10.91M	USD	3 Qtrs
Unrealized (gains) losses on marketable equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$84.51M	USD	3 Qtrs
Unrealized (gains) losses on marketable equity securities	`EquitySecuritiesFvNiUnrealizedGainLoss`	$-13.23M	USD	3 Qtrs
Impairment of non-marketable equity securities and other related assets	`OtherAssetImpairmentCharges`	$29.05M	USD	3 Qtrs
Impairment of non-marketable equity securities and other related assets	`OtherAssetImpairmentCharges`	$5.26M	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueAdjustmentsOfNoncontrollingInterestLiability`	$-99.78M	USD	3 Qtrs
Fair value adjustments of noncontrolling interest liability	`FairValueAdjustmentsOfNoncontrollingInterestLiability`	-	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$-23.00K	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$-104.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-11.43M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-8.36M	USD	3 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$32.38M	USD	3 Qtrs
Inventory, net	`IncreaseDecreaseInInventories`	$25.43M	USD	3 Qtrs
Prepaid expenses and other current assets, net	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.39M	USD	3 Qtrs
Prepaid expenses and other current assets, net	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.56M	USD	3 Qtrs
Other assets, net	`IncreaseDecreaseInOtherOperatingAssets`	$-2.28M	USD	3 Qtrs
Other assets, net	`IncreaseDecreaseInOtherOperatingAssets`	$-4.77M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities`	$26.58M	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAccruedAndOtherLiabilities`	$46.71M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-22.72M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-12.99M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$4.05M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$3.17M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-218.71M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-246.25M	USD	3 Qtrs
Purchase of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$629.90M	USD	3 Qtrs
Purchase of marketable debt securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$238.60M	USD	3 Qtrs
Maturity of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$828.70M	USD	3 Qtrs
Maturity of marketable debt securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$398.00M	USD	3 Qtrs
Purchase of non-marketable equity securities and other related assets	`PaymentsToAcquireEquitySecuritiesFvNi`	$5.59M	USD	3 Qtrs
Purchase of non-marketable equity securities and other related assets	`PaymentsToAcquireEquitySecuritiesFvNi`	$12.75M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.41M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$67.46M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$176.80M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$79.19M	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$290.00K	USD	3 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$2.50M	USD	3 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$5.74M	USD	3 Qtrs
Proceeds from issuances of common stock under employee stock purchase plan	`ProceedsFromStockPlans`	$6.70M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.52M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.11M	USD	3 Qtrs
Proceeds from follow-on public offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from follow-on public offering	`ProceedsFromIssuanceOfCommonStock`	$381.40M	USD	Point-in-time
Proceeds from follow-on public offering	`ProceedsFromIssuanceOfCommonStock`	$402.50M	USD	3 Qtrs
Payment of offering costs related to follow-on public offering	`PaymentsOfStockIssuanceCosts`	$20.48M	USD	3 Qtrs
Payment of offering costs related to follow-on public offering	`PaymentsOfStockIssuanceCosts`	-	USD	3 Qtrs
Joint Venture Acquisition	`PaymentsForJointVentureAcquisitionFinancingActivities`	$177.78M	USD	3 Qtrs
Joint Venture Acquisition	`PaymentsForJointVentureAcquisitionFinancingActivities`	-	USD	3 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`NoncashTenderOfferIssued`	$-14.24M	USD	3 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`NoncashTenderOfferIssued`	-	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.12M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$5.91M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$386.81M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-191.41M	USD	3 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-2.74M	USD	3 Qtrs
Net effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-1.94M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$315.42M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-333.68M	USD	3 Qtrs
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.61M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$141.95M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$457.36M	USD	Point-in-time
Cash, cash equivalents and restricted cashBeginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.61M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$141.95M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$457.36M	USD	Point-in-time
Cash, cash equivalents and restricted cashEnd of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$4.07M	USD	3 Qtrs
Operating lease liabilities arising from obtaining right-of-use assets	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$3.72M	USD	3 Qtrs
Purchase of property and equipment included in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$8.91M	USD	3 Qtrs
Purchase of property and equipment included in accounts payable and accrued liabilities	`CapitalExpendituresIncurredButNotYetPaid`	$1.80M	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$158.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.65M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$457.34M	USD	Point-in-time
Restricted cash included in other assets, net	`RestrictedCashNoncurrent`	$24.00K	USD	Point-in-time
Restricted cash included in other assets, net	`RestrictedCashNoncurrent`	$302.00K	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$158.61M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$141.95M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$457.36M	USD	Point-in-time
Total cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$492.29M	USD	Point-in-time

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Adjustments to additional paid in capital, stock issued, issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$21.13M	USD	3 Qtrs
Adjustments to additional paid in capital, stock issued, issuance costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$21.10M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$228.30M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$166.75M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$60.18M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$292.73M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$645.00M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$319.09M	USD	Point-in-time
Issuance of common stock upon follow-on public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	14.38M	shares	Point-in-time
Issuance of common stock upon follow-on public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$381.37M	USD	3 Qtrs
Issuance of common stock upon exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	40,868.00	shares	3 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$347.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$290.00K	USD	3 Qtrs
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$70.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.50M	USD	3 Qtrs
Vesting of common stock exercised early	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$8.00K	USD	3 Qtrs
Common stock issued under employee stock purchase plan (in shares)	`StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans`	0.00	shares	1 Quarter
Common stock issued under employee stock purchase plan (in shares)	`StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans`	0.00	shares	1 Quarter
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$5.74M	USD	3 Qtrs
Common stock issued under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$6.70M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$6.52M	USD	3 Qtrs
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.34M	USD	1 Quarter
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$3.00M	USD	1 Quarter
Taxes paid related to net share settlement of restricted stock units	`AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation`	$8.11M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$21.82M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$20.64M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$70.98M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$66.44M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$13.84M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.59M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-22.09M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.79M	USD	1 Quarter
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`AdjustmentsToAdditionalPaidInCapitalTenderOfferIssued`	$14.23M	USD	3 Qtrs
Tender offer issued in connection with the Joint Venture Acquisition and acquisition related costs	`AdjustmentsToAdditionalPaidInCapitalTenderOfferIssued`	$4.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-292.41M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-514.65M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.10M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-161.99M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$228.30M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$166.75M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$60.18M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$292.73M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$645.00M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$319.09M	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-161.99M	USD	1 Quarter
Net loss	`ProfitLoss`	$-514.65M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-86.10M	USD	1 Quarter
Net loss	`ProfitLoss`	$-292.41M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-19.35M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$3.31M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$15.78M	USD	3 Qtrs
Unrealized gain (loss) on available-for-sale securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.06M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-2.74M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-1.94M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-526.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax`	$-529.00K	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$13.84M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.59M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-22.09M	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.79M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-83.31M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-536.74M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-278.56M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-164.59M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.